News

B. Riley Financial Announces Strategic Wealth Management Sale

B. Riley Financial Announces Strategic Wealth Management Sale

B. Riley Financial Announces Strategic Wealth Management Sale

Enters into Agreement with Stifel Financial Corp.

B. Riley Financial, Inc. (NASDAQ: RILY), a company known for its diversified financial services, has exciting updates to share regarding its Wealth Management business. Recently, the company signed a definitive agreement to divest a portion of its traditional Wealth Management operations to Stifel Financial Corp. (NYSE: SF). This strategic move is anticipated to yield a net consideration ranging from $27 million to $35 million in cash. Notably, this transaction will not affect approximately 190 independent advisors and 90 tax professionals affiliated with B. Riley.

The transaction marks a pivotal moment as the company prepares for the transition of around 40 to 50 advisors and their associated customer accounts, expected to occur in early 2025. These accounts constitute a significant total of assets under management (AUM), projected to be between $3.5 billion and $4.5 billion as of the end of September.

Insights from Leadership

Bryant Riley, the Chairman and Co-CEO of B. Riley Financial, provided valuable insights into this transition: "The past year has served as a period of disruption for our Wealth Management brand. Various competitors capitalized on uncertainties stemming from our principal investments business. In response, we chose to pursue a proactive approach for those advisors seeking new beginnings. Partnering with Stifel, a well-respected entity in the industry, was an ideal choice. Our transition plan assures that these advisors can transfer their accounts smoothly, maintaining continuity without affecting daily operations."

Mr. Riley emphasized the importance of maintaining a strong presence in the Wealth Management sector, stating, "Even as we refocus B. Riley towards our core middle-market financial services, we recognize the significant advantages of keeping Wealth Management as an element of our overall portfolio. Our commitment remains firm in investing and enhancing our primary financial service offerings, and we are fully equipped to meet the needs of clients in the small- and mid-cap markets."

Transaction Details and Future Outlook

The transaction has gained approval from the Board of Directors and awaits necessary regulatory approvals along with other customary closing conditions. The successful conclusion of the deal is projected for early in the second quarter of 2025, marking the next chapter for both B. Riley and Stifel.

About B. Riley Financial

B. Riley Financial stands as a beacon of diversified financial solutions, delivering customized services tailored to meet the strategic, operational, and capital needs of its clientele. Renowned for leveraging its broad expertise, the company provides an array of collaborative financial solutions that span various stages of the business lifecycle.

The firm's capabilities include investment banking, institutional brokerage, private wealth and investment management, financial consulting, and many other financial services. B. Riley aims to optimize returns for shareholders and is involved in originating and underwriting senior secured loans to asset-rich entities.

Frequently Asked Questions

What did B. Riley Financial announce recently?

B. Riley Financial announced it signed an agreement to sell a portion of its Wealth Management business to Stifel Financial Corp. for an estimated net consideration of $27 million to $35 million in cash.

Will independent advisors be affected by the sale?

No, the transaction does not include approximately 190 independent advisors and 90 tax professionals associated with B. Riley.

When is the transaction expected to be completed?

The transaction is expected to close early in the second quarter of 2025, pending regulatory approvals.

What are the total assets under management involved in this deal?

The accounts transitioning to Stifel represent estimated total assets under management of between $3.5 billion and $4.5 billion.

Who is Bryant Riley?

Bryant Riley is the Chairman and Co-CEO of B. Riley Financial, and he provided insights on the strategic direction of the company and the recent sale.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles